Both in Pharmaceuticals
Opus Genetics vs Prelude Therapeutics Incorporated
Over the past year IRD returned +59.6% and PRLD returned +144.0%; their daily moves had a correlation of 0.05.
IRD +59.6% PRLD +144.0%Growth of $1, one year, split-adjusted
| Metric | IRD | PRLD |
|---|---|---|
| Price | $3.67 | $3.88 |
| Market cap | $305.3M | $309.6M |
| Today | +0.55% | −5.37% |
| 1 month | −18.6% | +2.4% |
| 6 months | −28.6% | −17.4% |
| Year to date | +82.6% | +33.8% |
| 1 year | +85.4% | +145.6% |
| Revenue growth (YoY) | −73.8% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1072.6% | −244.1% |
| P/E (TTM) | — | — |
| Price / sales | 31.0× | 13.8× |
| Net cash | $53.9M | $151.8M |
| Dividend yield | — | — |
| Volatility (60d) | 91.9% | 75.4% |
| Short % of float | 21.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).